Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Sugar-modified guanosine analogue | 2481279-61-0 | 99.9% | 614.54 | C25H33F2N6O8P | 5 MG
SDP

Catalog No. 5000221192
Encompass_Preferred

AL-611 is a research-use small-molecule HCV NS5B polymerase inhibitor described as a sugar-modified guanosine analogue with potent antiviral activity (EC50 = 5 nM). It is supplied as a high-purity solid and is intended for laboratory research only, not for human or clinical use.

  • Potent HCV NS5B polymerase inhibition (EC50 = 5 nM).
  • Sugar-modified guanosine analogue class of compound.
  • Molecular weight 614.54 g·mol-1.
  • Chemical formula C25H33F2N6O8P.
  • High purity, reported as 99.9% by HPLC.
  • Available in small-milligram sizes, with a 10 mM in 1 mL DMSO solution option.
  • For research use only; not for human or clinical use.

Catalog No. 50-002-21192 Supplier Medchemexpress LLC Supplier No. HY1453745MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

AL-611 is a research-use small-molecule HCV NS5B polymerase inhibitor described as a sugar-modified guanosine analogue with potent antiviral activity (EC50 = 5 nM). It is supplied as a high-purity solid and is intended for laboratory research only, not for human or clinical use.

  • Potent HCV NS5B polymerase inhibition (EC50 = 5 nM).
  • Sugar-modified guanosine analogue class of compound.
  • Molecular weight 614.54 g·mol-1.
  • Chemical formula C25H33F2N6O8P.
  • High purity, reported as 99.9% by HPLC.
  • Available in small-milligram sizes, with a 10 mM in 1 mL DMSO solution option.
  • For research use only; not for human or clinical use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.